Trials / Unknown
UnknownNCT00518934
Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to analyze the safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Study for safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cell |
Timeline
- First posted
- 2007-08-21
- Last updated
- 2007-08-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00518934. Inclusion in this directory is not an endorsement.